Aerosolized xylitol for ventilator-associated pneumonia

雾化木糖醇治疗呼吸机相关性肺炎

基本信息

  • 批准号:
    7389743
  • 负责人:
  • 金额:
    $ 12.5万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2005
  • 资助国家:
    美国
  • 起止时间:
    2005-04-01 至 2010-03-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): In this mentored patient-oriented research career development award, Lakshmi Durairaj seeks to gain expertise in clinical trials in the intensive care unit with particular emphasis on the prevention of ventilator associated pneumonia. This award will support the development of Dr. Durairaj into an independent researcher and an accomplished clinician-scientist. Drs. Joseph Zabner and James Torner will assume responsibility as the primary mentors to ensure a successful career development. The focus of this proposal is to study the effectiveness of a new intervention namely xylitol, a 5-carbon sugar, for the prevention of ventilator-associated pneumonia, a common nosocomial infection among ventilated patients. Dr. Durairaj has completed her didactic training in clinical epidemiology which also included classes in statistical methods and ethics and has a Master's degree in Epidemiology. Specific areas of career development include further training in statistical methods specific for clinical trials, design of various phases of interventional trials, data collection methods, statistical analysis and interpretation of results and planning future studies in the intensive care unit. Human airways are lined by a thin layer of liquid, which contains many antimicrobial peptides which are more potent in lower salt concentrations. Tracheal colonization is an important step in the pathogenesis of ventilator-associated pneumonia, which is an important cause of increased mortality, length of stay, and cost in the intensive care unit. Xylitol is a non-absorbable osmolyte which lowers the salt concentration of airway surface liquid and has the potential to decrease respiratory tract colonization and infection. For this proposal, Dr. Durairaj will assess airway retention time of xylitol, its effectiveness in decreasing tracheal colonization in a group of mechanically ventilated patients, and conduct a pilot safety study for prevention of this pneumonia in a randomized, double-blinded, controlled fashion. Near the termination of this award, she will submit a competitive R-01 proposal to study xylitol for prevention of ventilator-associated pneumonia. Dr. Durairaj will interface with experts in clinical research, immunology, pulmonary and critical care medicine and infectious diseases at her institution. This intellectually rich environment will help foster the career development, providing ample opportunity for critical review throughout the period of this award. Both the mentor and the institution are highly committed to Dr. Durairaj's academic success.
描述(由申请人提供):

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

LAKSHMI DURAIRAJ其他文献

LAKSHMI DURAIRAJ的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('LAKSHMI DURAIRAJ', 18)}}的其他基金

Iowa Phase II Clinical Trials of Novel Therapies for Lung Diseases (U01
爱荷华州肺部疾病新疗法的 II 期临床试验 (U01
  • 批准号:
    8099575
  • 财政年份:
    2010
  • 资助金额:
    $ 12.5万
  • 项目类别:
Iowa Phase II Clinical Trials of Novel Therapies for Lung Diseases (U01
爱荷华州肺部疾病新疗法的 II 期临床试验 (U01
  • 批准号:
    8318831
  • 财政年份:
    2010
  • 资助金额:
    $ 12.5万
  • 项目类别:
Iowa Phase II Clinical Trials of Novel Therapies for Lung Diseases (U01
爱荷华州肺部疾病新疗法的 II 期临床试验 (U01
  • 批准号:
    7879718
  • 财政年份:
    2010
  • 资助金额:
    $ 12.5万
  • 项目类别:
VAP GENETICS STUDY
VAP 遗传学研究
  • 批准号:
    7604900
  • 财政年份:
    2007
  • 资助金额:
    $ 12.5万
  • 项目类别:
Aerosolized xylitol for ventilator-associated pneumonia
雾化木糖醇治疗呼吸机相关性肺炎
  • 批准号:
    6909404
  • 财政年份:
    2005
  • 资助金额:
    $ 12.5万
  • 项目类别:
Aerosolized xylitol for ventilator-associated pneumonia
雾化木糖醇治疗呼吸机相关性肺炎
  • 批准号:
    7047764
  • 财政年份:
    2005
  • 资助金额:
    $ 12.5万
  • 项目类别:
Aerosolized xylitol for ventilator-associated pneumonia
雾化木糖醇治疗呼吸机相关性肺炎
  • 批准号:
    7214066
  • 财政年份:
    2005
  • 资助金额:
    $ 12.5万
  • 项目类别:
Aerosolized xylitol for ventilator-associated pneumonia
雾化木糖醇治疗呼吸机相关性肺炎
  • 批准号:
    7589696
  • 财政年份:
    2005
  • 资助金额:
    $ 12.5万
  • 项目类别:

相似海外基金

New technologies for targeted delivery of anti-bacterial agents
抗菌药物靶向递送新技术
  • 批准号:
    1654774
  • 财政年份:
    2015
  • 资助金额:
    $ 12.5万
  • 项目类别:
    Studentship
Targeting bacterial phosphatases for novel anti-bacterial agents.
针对细菌磷酸酶的新型抗菌剂。
  • 批准号:
    8416313
  • 财政年份:
    2012
  • 资助金额:
    $ 12.5万
  • 项目类别:
Targeting bacterial phosphatases for novel anti-bacterial agents.
针对细菌磷酸酶的新型抗菌剂。
  • 批准号:
    8298885
  • 财政年份:
    2012
  • 资助金额:
    $ 12.5万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了